Magnetic resonance imaging of the breast

recommendations from the EUSOMA working group

Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J. Gilbert, Thomas Helbich, Sylvia H Heywang-Köbrunner, Werner A Kaiser, Michael J Kerin, Robert E Mansel, Lorenza Marotti, Laura Martincich, Louis Mauriac, Hanne Meijers-Heijboer, Roberto Orecchia, Pietro Panizza, Antonio Ponti, Arnie D Purushotham, Peter Regitnig & 3 others Marco Rosselli Del Turco, Fabienne Thibault, Robin Wilson

Research output: Contribution to journalArticle

483 Citations (Scopus)

Abstract

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.
Original languageEnglish
Pages (from-to)1296-1316
Number of pages21
JournalEuropean Journal of Cancer
Volume46
Issue number8
Early online date19 Mar 2010
DOIs
Publication statusPublished - May 2010

Fingerprint

Breast
Magnetic Resonance Imaging
Breast Neoplasms
Inflammatory Breast Neoplasms
Technology
Breast Diseases
Disease Management
Education
Recurrence
Drug Therapy
Research
Therapeutics

Keywords

  • breast diseases
  • magnetic resonance imaging

Cite this

Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F. J., ... Wilson, R. (2010). Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. European Journal of Cancer, 46(8), 1296-1316. https://doi.org/10.1016/j.ejca.2010.02.015

Magnetic resonance imaging of the breast : recommendations from the EUSOMA working group. / Sardanelli, Francesco; Boetes, Carla; Borisch, Bettina; Decker, Thomas; Federico, Massimo; Gilbert, Fiona J.; Helbich, Thomas; Heywang-Köbrunner, Sylvia H; Kaiser, Werner A; Kerin, Michael J; Mansel, Robert E; Marotti, Lorenza; Martincich, Laura; Mauriac, Louis; Meijers-Heijboer, Hanne; Orecchia, Roberto; Panizza, Pietro; Ponti, Antonio; Purushotham, Arnie D; Regitnig, Peter; Del Turco, Marco Rosselli; Thibault, Fabienne; Wilson, Robin.

In: European Journal of Cancer, Vol. 46, No. 8, 05.2010, p. 1296-1316.

Research output: Contribution to journalArticle

Sardanelli, F, Boetes, C, Borisch, B, Decker, T, Federico, M, Gilbert, FJ, Helbich, T, Heywang-Köbrunner, SH, Kaiser, WA, Kerin, MJ, Mansel, RE, Marotti, L, Martincich, L, Mauriac, L, Meijers-Heijboer, H, Orecchia, R, Panizza, P, Ponti, A, Purushotham, AD, Regitnig, P, Del Turco, MR, Thibault, F & Wilson, R 2010, 'Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group', European Journal of Cancer, vol. 46, no. 8, pp. 1296-1316. https://doi.org/10.1016/j.ejca.2010.02.015
Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. European Journal of Cancer. 2010 May;46(8):1296-1316. https://doi.org/10.1016/j.ejca.2010.02.015
Sardanelli, Francesco ; Boetes, Carla ; Borisch, Bettina ; Decker, Thomas ; Federico, Massimo ; Gilbert, Fiona J. ; Helbich, Thomas ; Heywang-Köbrunner, Sylvia H ; Kaiser, Werner A ; Kerin, Michael J ; Mansel, Robert E ; Marotti, Lorenza ; Martincich, Laura ; Mauriac, Louis ; Meijers-Heijboer, Hanne ; Orecchia, Roberto ; Panizza, Pietro ; Ponti, Antonio ; Purushotham, Arnie D ; Regitnig, Peter ; Del Turco, Marco Rosselli ; Thibault, Fabienne ; Wilson, Robin. / Magnetic resonance imaging of the breast : recommendations from the EUSOMA working group. In: European Journal of Cancer. 2010 ; Vol. 46, No. 8. pp. 1296-1316.
@article{ba1192b9566f4601abf70a906429526e,
title = "Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group",
abstract = "The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.",
keywords = "breast diseases, magnetic resonance imaging",
author = "Francesco Sardanelli and Carla Boetes and Bettina Borisch and Thomas Decker and Massimo Federico and Gilbert, {Fiona J.} and Thomas Helbich and Heywang-K{\"o}brunner, {Sylvia H} and Kaiser, {Werner A} and Kerin, {Michael J} and Mansel, {Robert E} and Lorenza Marotti and Laura Martincich and Louis Mauriac and Hanne Meijers-Heijboer and Roberto Orecchia and Pietro Panizza and Antonio Ponti and Purushotham, {Arnie D} and Peter Regitnig and {Del Turco}, {Marco Rosselli} and Fabienne Thibault and Robin Wilson",
note = "Copyright {\circledC} 2010 Elsevier Ltd. All rights reserved.",
year = "2010",
month = "5",
doi = "10.1016/j.ejca.2010.02.015",
language = "English",
volume = "46",
pages = "1296--1316",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER APPL SCI PUBL LTD",
number = "8",

}

TY - JOUR

T1 - Magnetic resonance imaging of the breast

T2 - recommendations from the EUSOMA working group

AU - Sardanelli, Francesco

AU - Boetes, Carla

AU - Borisch, Bettina

AU - Decker, Thomas

AU - Federico, Massimo

AU - Gilbert, Fiona J.

AU - Helbich, Thomas

AU - Heywang-Köbrunner, Sylvia H

AU - Kaiser, Werner A

AU - Kerin, Michael J

AU - Mansel, Robert E

AU - Marotti, Lorenza

AU - Martincich, Laura

AU - Mauriac, Louis

AU - Meijers-Heijboer, Hanne

AU - Orecchia, Roberto

AU - Panizza, Pietro

AU - Ponti, Antonio

AU - Purushotham, Arnie D

AU - Regitnig, Peter

AU - Del Turco, Marco Rosselli

AU - Thibault, Fabienne

AU - Wilson, Robin

N1 - Copyright © 2010 Elsevier Ltd. All rights reserved.

PY - 2010/5

Y1 - 2010/5

N2 - The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.

AB - The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.

KW - breast diseases

KW - magnetic resonance imaging

U2 - 10.1016/j.ejca.2010.02.015

DO - 10.1016/j.ejca.2010.02.015

M3 - Article

VL - 46

SP - 1296

EP - 1316

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 8

ER -